Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study

被引：0
|
作者：
Sivesh K. Kamarajah
Steven A. White
Samer A. Naffouje
George I Salti
Fadi Dahdaleh
机构：
[1] The Freeman Hospital,Department of HPB and Transplant Surgery
[2] Newcastle University,Institute of Cellular Medicine
[3] University Hospital Birmingham NHS Trust,Department of Surgery, Queen Elizabeth Hospital Birmingham
[4] H. Lee Moffitt Cancer and Research Institute,Department of Surgical Oncology
[5] University of Illinois Hospital and Health Sciences System,Department of General Surgery
[6] Edward-Elmhurst Health,Department of Surgical Oncology
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6790 / 6802
页数：12
相关论文
共 50 条
  • [21] The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
    Ghaneh, Paula
    Kleeff, Jorg
    Halloran, Christopher M.
    Raraty, Michael
    Jackson, Richard
    Melling, James
    Jones, Owain
    Palmer, Daniel H.
    Cox, Trevor F.
    Smith, Chloe J.
    O'Reilly, Derek A.
    Izbicki, Jakob R.
    Scarfe, Andrew G.
    Valle, Juan W.
    McDonald, Alexander C.
    Carter, Ross
    Tebbutt, Niall C.
    Goldstein, David
    Padbury, Robert
    Shannon, Jennifer
    Dervenis, Christos
    Glimelius, Bengt
    Deakin, Mark
    Anthoney, Alan
    Lerch, Markus M.
    Mayerle, Julia
    Olah, Attila
    Rawcliffe, Charlotte L.
    Campbell, Fiona
    Strobel, Oliver
    Buechler, Markus W.
    Neoptolemos, John P.
    ANNALS OF SURGERY, 2019, 269 (03) : 520 - 529
  • [22] Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma
    Xie, Hao
    Liu, Junjia
    Ogden, John R.
    Yin, Jun
    Jatoi, Aminah
    Hubbard, Joleen M.
    McWilliams, Robert R.
    Mahipal, Amit
    Petersen, Gloria M.
    Bekaii-Saab, Tanios S.
    Ma, Wen Wee
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (08): : 586 - 590
  • [23] Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
    Mazzone, Elio
    Knipper, Sophie
    Mistretta, Francesco A.
    Tian, Zhe
    Preisser, Felix
    Gallina, Andrea
    Soulieres, Denis
    Tilki, Derya
    Montorsi, Francesco
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Wisnivesky, Juan
    Karakiewicz, Pierre, I
    CANCER EPIDEMIOLOGY, 2019, 58 : 83 - 88
  • [24] Addition of Adjuvant Radiation to Adjuvant Chemotherapy Does Not Improve Survival in Patients with Advanced Pancreatic Adenocarcinoma Treated with Neoadjuvant Chemotherapy
    Ruiz, Meritxell
    Leyva-Alvizo, Adolfo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S145 - S146
  • [25] Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
    Latenstein, Anouk E. J.
    Mackay, Tara M.
    Creemers, Geert-Jan
    van Eijck, Casper H. J.
    de Groot, Jan Willem B.
    Haj Mohammad, Nadia
    Homs, Marjolein Y. V.
    van Laarhoven, Hanneke W. M.
    Molenaar, I. Quintus
    ten Tije, Bert-Jan
    de Vos-Geelen, Judith
    Besselink, Marc G.
    van der Geest, Lydia G. M.
    Wilmink, Johanna W.
    ACTA ONCOLOGICA, 2020, 59 (06) : 705 - 712
  • [26] Does Adjuvant Chemotherapy Provide Additional Survival Benefit After Neoadjuvant Chemotherapy or Chemoradiotherapy and Esophagectomy for Esophageal Adenocarcinoma?
    Kamarajah, Sivesh
    Markar, Sheraz
    Phillips, Alexander
    Kunene, Victoria
    Fackrell, David
    Salti, George
    Dahdaleh, Fadi
    Griffiths, Ewen
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [27] Neoadjuvant Chemotherapy May Be Key to Improving Mortality and Survival for Octogenarians with Pancreatic Ductal Adenocarcinoma
    Hays, Sarah B.
    Kuchta, Kristine
    Rojas, Aram
    Farah, Emile
    Abreu, Andres A.
    Ranson, Kristen
    Chopra, Asmita
    Kannan, Amudhan
    Radi, Imad
    Paniccia, Alessandro
    Boone, Brian
    Polanco, Patricio M.
    Talamonti, Mark
    Zureikat, Amer
    Zeh, Herbert J., III
    Hogg, Melissa
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S198 - S198
  • [28] Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
    Labori, Knut J.
    Katz, Matthew H.
    Tzeng, Ching W.
    Bjornbeth, Bjorn A.
    Cvancarova, Milada
    Edwin, Bjorn
    Kure, Elin H.
    Eide, Tor J.
    Dueland, Svein
    Buanes, Trond
    Gladhaug, Ivar P.
    ACTA ONCOLOGICA, 2016, 55 (03) : 265 - 277
  • [29] Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
    Schmocker, Ryan K.
    Delitto, Daniel
    Wright, Michael J.
    Ding, Ding
    Cameron, John L.
    Lafaro, Kelly J.
    Burns, William R.
    Wolfgang, Christopher L.
    Burkhart, Richard A.
    He, Jin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 405 - 413
  • [30] What is the Impact of Neoadjuvant Chemotherapy on Survival after Palliative Procedures for Pancreatic Ductal Adenocarcinoma?
    Halle-Smith, James
    Roberts, Keith
    BRITISH JOURNAL OF SURGERY, 2022, 109
12345